3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Burkitt Lymphoma
13
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
4
Lymphoma, Large B-Cell, Diffuse
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Prostatic Neoplasms
2
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
2
Leukemia, Biphenotypic, Acute
2
Plasmablastic Lymphoma
1
Multiple Myeloma
1
Melanoma
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma
1
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
1
HTLV-I Infections
1
Down Syndrome
1
Carcinoma, Merkel Cell
1
Carcinoma, Basal Cell
1
Ann Arbor Stage II Mantle Cell Lymphoma
1
Interventions
X-Rays
6
Temozolomide
6
Specimen Handling
6
Nuclear Medicine Department, Hospital
6
Magnetic Resonance Spectroscopy
6
Biopsy
6
Phantoms, Imaging
5
Irinotecan
4
Cyclophosphamide
4
dinutuximab
3
ulixertinib
2
tipifarnib
2
selpercatinib
2
olaparib
2
larotrectinib
2
ivosidenib
2
fludarabine phosphate
2
erdafitinib
2
ensartinib
2
Topotecan
2
trametinib
1
tazemetostat
1
talazoparib
1
saponin QA-21V1
1
palbociclib
1
lutetium Lu 177 dotatate
1
irinotecan sucrosofate
1
fludarabine
1
dabrafenib
1
Vincristine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neuroblastoma
×
deltacortene
×
30 days
×
Clear all
No trials found.